Age, Inflammation, and Disease Location Are Critical Determinants of Intestinal Expression of SARS-CoV-2 Receptor ACE2 and TMPRSS2 in Inflammatory Bowel Disease
暂无分享,去创建一个
[1] S. Danese,et al. Management of IBD during the COVID-19 outbreak: resetting clinical priorities , 2020, Nature Reviews Gastroenterology & Hepatology.
[2] Lanjuan Li,et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms , 2020, Gut.
[3] Fabian J Theis,et al. SARS-CoV-2 Receptor ACE2 is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Enriched in Specific Cell Subsets Across Tissues , 2020, SSRN Electronic Journal.
[4] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[5] H. Shan,et al. Evidence for Gastrointestinal Infection of SARS-CoV-2 , 2020, Gastroenterology.
[6] B. Graham,et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.